Core Scientific, Inc. Common Stock
CORZ
CORZ was delisted on the 30th of December, 2022.
137 hedge funds and large institutions have $121M invested in Core Scientific, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 54 increasing their positions, 23 reducing their positions, and 24 closing their positions.
2,678% more call options, than puts
Call options by funds: $7.78M | Put options by funds: $280K
135% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 23
15% more capital invested
Capital invested by funds: $105M → $121M (+$15.8M)
3% less funds holding
Funds holding: 141 → 137 (-4)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$19.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17.6M |
| 3 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$8.6M |
| 4 |
BlackRock
New York
|
+$4.45M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.04M |
| 2 |
Two Sigma Investments
New York
|
-$2.33M |
| 3 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$1.14M |
| 4 |
Jane Street
New York
|
-$484K |
| 5 |
Morgan Stanley
New York
|
-$391K |
CORZ Hedge Fund Activity: Q3 2022 in Review
137 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Core Scientific, Inc. Common Stock (CORZ) for Q3 2022, worth a combined $121M — up 15% from $105M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of CORZ and 21 opened new positions — a net loss of 3 holders — while 23 trimmed existing stakes and 54 added.
The largest buyer was Invesco, adding an estimated $19.7M. The largest seller was Citadel Advisors, exiting entirely with an estimated $4.04M sold.
- 137 institutional investors held Core Scientific, Inc. Common Stock (CORZ) as of Q3 2022, down from 141 in Q2 2022.
- Funds reported $121M of Core Scientific, Inc. Common Stock stock for Q3 2022, up 15% quarter-over-quarter.
- 21 funds opened new Core Scientific, Inc. Common Stock positions in Q3 2022 and 24 closed out, a net change of -3 holders.
- The largest Core Scientific, Inc. Common Stock buyer in Q3 2022 was Invesco, an estimated $19.7M added.
- The largest Core Scientific, Inc. Common Stock seller in Q3 2022 was Citadel Advisors, an estimated $4.04M sold.
Based on aggregated 13F filings for Q3 2022.